NVCT

19.3902.27%
MC

Michael Carson

Vice President of Finance

Mr. Michael Carson, CPA, serves as Vice President of Finance and served as Interim Chief Financial Officer at Nuvectis Pharma, Inc. since March 21, 2022 and served as its Vice President of Finance until March 21, 2022. He served as Vice President of Finance at XyloCor Therapeutics, Inc since 2019 until 2021. He serves as Chief Financial Officer of MedLite ID, Inc. Mr. Carson has progressive accounting experience in the healthcare industry with both publicly traded and pre-IPO companies. Recently, he was the Director of FP&A at Neuronetics. During 2019, he consulted for Smiths Medical, Inc., a division of Smiths Group, as Global Controller along with serving as Vice President of Finance in a consulting role for several other biopharmaceutical and medical device companies. At Smiths Medical, he led a team responsible for accounting, treasury and foreign currency exposure. From 2015 to 2019, he served as Director of Financial Planning and Analysis at Neuronetics. In this role, he served as the second in command to the Chief Financial Officer and held responsibilities for strategic planning, financial execution, investor relations, and controllership. In the past, he has held several finance and accounting positions at Abbott Laboratories (NYSE: ABT) and served as an auditor at Crowe LLP and Deloitte. Mr. Carson holds a Bachelor of Arts in Business and Economics along with a Bachelor of Science in Mechanical Engineering from Lafayette College in Pennsylvania. Mr. Carson is a licensed Certified Public Accountant with the CGMA designation in the Commonwealth of Pennsylvania.

Positions